English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/159450
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

AuthorsMiotto, Paolo; Comas, Iñaki ; Rodwell, Timothy C.
Issue Date28-Dec-2017
PublisherEuropean Respiratory Society
CitationEuropean Respiratory Journal 50(6): 1701354 (2017)
AbstractA clear understanding of the genetic basis of antibiotic resistance in Mycobacterium tuberculosis is required to accelerate the development of rapid drug susceptibility testing methods based on genetic sequence.Raw genotype-phenotype correlation data were extracted as part of a comprehensive systematic review to develop a standardised analytical approach for interpreting resistance associated mutations for rifampicin, isoniazid, ofloxacin/levofloxacin, moxifloxacin, amikacin, kanamycin, capreomycin, streptomycin, ethionamide/prothionamide and pyrazinamide. Mutation frequencies in resistant and susceptible isolates were calculated, together with novel statistical measures to classify mutations as high, moderate, minimal or indeterminate confidence for predicting resistance.We identified 286 confidence-graded mutations associated with resistance. Compared to phenotypic methods, sensitivity (95% CI) for rifampicin was 90.3% (89.6-90.9%), while for isoniazid it was 78.2% (77.4-79.0%) and their specificities were 96.3% (95.7-96.8%) and 94.4% (93.1-95.5%), respectively. For second-line drugs, sensitivity varied from 67.4% (64.1-70.6%) for capreomycin to 88.2% (85.1-90.9%) for moxifloxacin, with specificity ranging from 90.0% (87.1-92.5%) for moxifloxacin to 99.5% (99.0-99.8%) for amikacin.This study provides a standardised and comprehensive approach for the interpretation of mutations as predictors of M. tuberculosis drug-resistant phenotypes. These data have implications for the clinical interpretation of molecular diagnostics and next-generation sequencing as well as efficient individualised therapy for patients with drug-resistant tuberculosis.
DescriptionMiotto, Paolo. et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 2017; 50: 1701354. [https://doi.org/10.1183/13993003.01354-2017]. 13 páginas, 2 figuras, 4 tablas.
Publisher version (URL)http://dx.doi.org/10.1183/13993003.01354-2017
URIhttp://hdl.handle.net/10261/159450
DOI10.1183/13993003.01354-2017
ISSN0903-1936
E-ISSN1399-3003
Appears in Collections:(IBV) Artículos
Files in This Item:
File Description SizeFormat 
2017 Eur Respir J 050-1701354.pdf488,14 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.